Pacira BioSciences has agreed to sell its subsidiary Pacira CryoTech and its handheld cryoanalgesia devices (including iovera®) to Zimmer Biomet's subsidiary for up to $140 million, including $70 million upfront and up to $70 million in milestones based on future revenue. The deal is expected to close in the third quarter of 2026. About 66 employees, representing 8% of Pacira's workforce, are expected to be hired by the buyer.
View Full Filing (SEC EDGAR)